PPT-Medication Treatment for Opioid Use Disorder

Brian Grahan MD PhD Addiction Medicine Internal Medicine 672018 Disclosures This educational initiative is funded by a grant from the Minnesota Department of Human Services I have no financial interests to disclose . for Opioid Use Disorders. Melissa Weimer, DO, MCR. Assistant Professor of Medicine, OHSU. Medical Director, CODA, Inc.. Learning Objectives. Understand the basis for medication assisted treatment and how it fits into one model of addiction treatment. John e lopes . j. r. .. , . dhs. c. , pa-c. A. ssociate Professor, . Physician Assistant Program. Central Michigan University. and . Project Director. Medication-assisted Treatment Waiver Training Initiative. Presented by:. NJATOD Officers. Barbara . Schlichting. , NJATOD Secretary, Somerset Treatment Services . Christie . Hanvey. , NJATOD Vice President, Spectrum Healthcare Center. . Maiysha. Ware, NJATOD President, The . Improvement Protocol (TIP) 63:. Medications for Opioid Use Disorder . Name of Presenter . Position Title. Substance Abuse and Mental Health Services Administration . U.S. Department of Health and Human Services. Adapt|Compass. Behavioral Health | SouthRiver Community Health Center. Douglas County Pain Summit, March 21, 2017. Best Practices in . Medication Assisted Treatment . for Opioid Use Disorder. Objectives. PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine. Assessing Opioid Use Disorder, part . 2. Objectives. Identify key features of opioid use disorder.. Understand . the evaluation of opioid use disorder in the setting of chronic pain.. Angeline Stanislaus, MD. Chief Medical director- adult services. Missouri . Dept. of Mental Health. How many people are dying each day?. 115. Overdoses. Missouri- Total number of opioid related death 2017. CA . Hub. and Spoke MAT . ECHO® Clinic. Faculty: Candy Stockton-Joreteg, MD, Larissa Mooney, MD, Gloria Miele, Ph.D., Thomas E. Freese, Ph.D.. Monday, December 3. rd. , 2018. This . project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under contract number HHSH250201600015C. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government. Nick Szubiak, MSW, LCSW. Director, Clinical Excellence in Addictions. National Council for Behavioral Health. Objectives. Understand why and how Medication Assisted Treatment works and why we don't use it by challenging the way we view, judge and think about addiction.. MAT BASICS Peter Mason MD Medical Director Region 1 IDN Opioid Use Disorder (OUD) Opioid Use Disorder (OUD): A medical condition characterized by a problematic pattern of opioid use that causes clinically significant impairment or distress. : . Addressing Fear and Discrimination (Part I). Sharon Morello RN, BSN . Opioid Epidemic and Substance Use Disorders. . Heroin use climbed then stabilized . See table 7.2 in the 2017 NSDUH detailed tables for additional information and the 2017 CDC Mortality Data.. www.hivguidelines.org. JANUARY 2021. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. Increase the number of clinicians in outpatient settings offering evidence-based treatment to individuals with opioid use disorder.. This . project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under contract number HHSH250201600015C. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.. Providing Compassionate care. Grace Katie Bell MSN RN CARN PHN. Chapa-De Medication Assisted Treatment –one program, two sites. Our Team. Annie . Mascorro. – RN Case Manager . Auburn. Katie Bell - RN Case Manager .